PerkinElmer, Inc. Launches Prenatal BACs-on-Beads(TM) Assay in Europe, a New In Vitro Diagnostic for Detection of Multiple Genetic Diseases

MONTPELLIER, France--(BUSINESS WIRE)--At the 10th International Congress on Preimplantation Genetic Diagnosis, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of its new prenatal BACs-on-Beads (BoBs)TM in vitro diagnostic (IVD) assay for rapid prenatal testing of multiple genetic diseases, for use in the European Union.
MORE ON THIS TOPIC